Long-term risk of herpes zoster following COVID-19: A retrospective cohort study of 2 442 686 patients

Journal of Medical VirologyVolume 95, Issue 7 e28903 LETTER TO THE EDITOR Long-term risk of herpes zoster following COVID-19: A retrospective cohort study of 2 442 686 patients Wen-Chun Lin, Wen-Chun Lin orcid.org/0000-0002-9855-7151 Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan Department of Otolaryngology, Head and Neck Surgery, Taichung Veterans General Hospital, Taichung, TaiwanSearch for more papers by this authorJames Cheng-Chung Wei, Corresponding Author James Cheng-Chung Wei [email protected] Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan Department of Allergy, Immunology & Rheumatology, Chung Shan Medical University Hospital, Taichung, Taiwan Graduate Institute of Integrated Medicine, China Medical University, Taichung, Taiwan Correspondence James Cheng-Chung Wei, No. 110, Sec. 1, Jianguo N. Rd., South District, Taichung City 40201, Taiwan. Email: [email protected]Search for more papers by this author Wen-Chun Lin, Wen-Chun Lin orcid.org/0000-0002-9855-7151 Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan Department of Otolaryngology, Head and Neck Surgery, Taichung Veterans General Hospital, Taichung, TaiwanSearch for more papers by this authorJames Cheng-Chung Wei, Corresponding Author James Cheng-Chung Wei [email protected] Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan Department of Allergy, Immunology & Rheumatology, Chung Shan Medical University Hospital, Taichung, Taiwan Graduate Institute of Integrated Medicine, China Medical University, Taichung, Taiwan Correspondence James Cheng-Chung Wei, No. 110, Sec. 1, Jianguo N. Rd., South District, Taichung City 40201, Taiwan. Email: [email protected]Search for more papers by this author First published: 30 June 2023 https://doi.org/10.1002/jmv.28903Citations: 1Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1Chen YC, Ho CH, Liu TH, et al. Long-term risk of herpes zoster following COVID-19: a retrospective cohort study of 2 442 686 patients. J Med Virol. 2023; 95(4):e28745. 2Hertel M, Heiland M, Nahles S, et al. Real-world evidence from over one million COVID-19 vaccinations is consistent with reactivation of the varicella-zoster virus. J Eur Acad Dermatol Venereol. 2022; 36(8): 1342-1348. 3Akpandak I, Miller DC, Sun Y, Arnold BF, Kelly JD, Acharya NR. Assessment of herpes zoster risk among recipients of COVID-19 vaccine. JAMA Network Open. 2022; 5(11):e2242240. Citing Literature Volume95, Issue7July 2023e28903 ReferencesRelatedInformation